Cargando…
In vitro and in vivo antischistosomal activity of ferroquine derivatives
BACKGROUND: Schistosomiasis is a neglected tropical disease and drug-repurposing is a useful strategy to fill its exhausted drug development pipeline. The ferrocenyl analogue of chloroquine, ferroquine, is an antimalarial in late-stage drug development. The aim of the present work was to study the a...
Autores principales: | Keiser, Jennifer, Vargas, Mireille, Rubbiani, Riccardo, Gasser, Gilles, Biot, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164798/ https://www.ncbi.nlm.nih.gov/pubmed/25190030 http://dx.doi.org/10.1186/1756-3305-7-424 |
Ejemplares similares
-
Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action
por: Dubar, Faustine, et al.
Publicado: (2008) -
The antimalarial ferroquine: from bench to clinic
por: Biot, C., et al.
Publicado: (2011) -
Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
por: Angeli, Andrea, et al.
Publicado: (2022) -
Ferroquine, the next generation antimalarial drug, has antitumor activity
por: Kondratskyi, Artem, et al.
Publicado: (2017) -
Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box
por: Ingram-Sieber, Katrin, et al.
Publicado: (2014)